Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | |
| Sales | 5,251 |
| Cost of Goods | 2,172 |
| Gross Profit | 3,079 |
| Operating Expenses | 16,375 |
| Operating Income | -13,124 |
| Interest Expense | 88 |
| Other Income | 32 |
| Pre-tax Income | -13,180 |
| Net Income Continuous | -13,180 |
| Net Income | $-13,180 |
| EPS Basic Total Ops | -10.64 |
| EPS Basic Continuous Ops | -10.64 |
| EPS Diluted Total Ops | -10.64 |
| EPS Diluted Continuous Ops | -10.64 |
| EBITDA(a) | $-12,625 |